The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma

The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma

Alpha-fetoprotein producing gastric carcinoma (AFP-PGC) is a rare cancer for which limited data on the clinicopathological features and treatment modalities exist. The aim of this study was to compare the efficacy of modified docetaxel-cisplatin-5-fluorouracil (mDCF) as the first-line chemotherapy...

Full description

Bibliographic Details
Main Authors: Yakup Bozkaya, Mutlu Doğan, Ozan Yazıcı, Gökmen Umut Erdem, Nebi Serkan Demirci, Nurullah Zengin
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2017-05-01
Series:Bosnian Journal of Basic Medical Sciences
Subjects:
Alpha-fetoprotein
alpha-fetoprotein producing gastric carcinoma
gastric carcinoma
modified docetaxel-cisplatin-5-fluorouracil
chemotherapy
Online Access:https://bjbms.org/ojs/index.php/bjbms/article/view/1684

Internet

https://bjbms.org/ojs/index.php/bjbms/article/view/1684

Similar Items